R104H may suppress transthyretin amyloidogenesis by thermodynamic stabilization, but not by the kinetic mechanism characterizing T119 interallelic trans-suppression
- 1 January 2006
- journal article
- research article
- Published by Taylor & Francis in Amyloid
- Vol. 13 (2) , 57-66
Abstract
The tetrameric protein transthyretin (TTR) forms amyloid fibrils upon dissociation and subsequent monomer misfolding, enabling misassembly. Remarkably, the aggregation of one of over 100 destabilized TTR variants leads to familial amyloid disease. It is known that trans-suppression mediated by the incorporation of T119M subunits into tetramers otherwise composed of the most common familial variant V30M, ameliorates disease by substantially slowing the rate of tetramer dissociation, a mechanism referred to as kinetic stabilization of the native state. R104H TTR has been reported to be non-pathogenic, and recently, this variant has been invoked as a trans-suppressor of amyloid fibril formation. Here, we demonstrate that the trans-suppression mechanism of R104H does not involve kinetic stabilization of the tetrameric structure, instead its modest trans-suppression most likely results from the thermodynamic stabilization of the tetrameric TTR structure. Thermodynamic stabilization increases the fraction of tetramer at the expense of the misfolding competent monomer decreasing the ability of TTR to aggregate into amyloid fibrils. As a consequence of this stabilization mechanism, R104H may be capable of protecting patients with modestly destabilizing mutations against amyloidosis by slightly lowering the overall population of monomeric protein that can misfold and form amyloid.Keywords
This publication has 30 references indexed in Scilit:
- Genetic study of transthyretin amyloid neuropathies: carrier risks among French and Portuguese familiesJournal of Medical Genetics, 2003
- D18G Transthyretin Is Monomeric, Aggregation Prone, and Not Detectable in Plasma and Cerebrospinal Fluid: A Prescription for Central Nervous System Amyloidosis?Biochemistry, 2003
- Energetic Characteristics of the New Transthyretin Variant A25T May Explain Its Atypical Central Nervous System PathologyLaboratory Investigation, 2003
- Familial transthyretin-type amyloid polyneuropathy in JapanNeurology, 2002
- Transthyretin: a review from a structural perspectiveCellular and Molecular Life Sciences, 2001
- Genotypic-phenotypic variations in a series of 65 patients with familial amyloid polyneuropathyNeurology, 1998
- Amyloid fibril formation and protein misassembly: a structural quest for insights into amyloid and prion diseasesStructure, 1997
- Alternative conformations of amyloidogenic proteins govern their behaviorCurrent Opinion in Structural Biology, 1996
- Transthyretin Pro55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvementHuman Genetics, 1992
- Fibril in senile systemic amyloidosis is derived from normal transthyretin.Proceedings of the National Academy of Sciences, 1990